Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study.
Petta S, Marzioni M, Russo P, Aghemo A, Alberti A, Ascione A, Antinori A, Bruno R, Bruno S, Chirianni A, Gaeta GB, Giannini EG, Merli M, Messina V, Montilla S, Perno CF, Puoti M, Raimondo G, Rendina M, Silberstein FC, Villa E, Zignego AL, Pani L, Craxì A; ABACUS study group; AIFA team. Petta S, et al. Lancet Gastroenterol Hepatol. 2017 Jun;2(6):427-434. doi: 10.1016/S2468-1253(17)30048-1. Epub 2017 Apr 10. Lancet Gastroenterol Hepatol. 2017. PMID: 28497758
Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals.
Faillaci F, Marzi L, Critelli R, Milosa F, Schepis F, Turola E, Andreani S, Vandelli G, Bernabucci V, Lei B, D'Ambrosio F, Bristot L, Cavalletto L, Chemello L, Sighinolfi P, Manni P, Maiorana A, Caporali C, Bianchini M, Marsico M, Turco L, de Maria N, Del Buono M, Todesca P, di Lena L, Romagnoli D, Magistri P, di Benedetto F, Bruno S, Taliani G, Giannelli G, Martinez-Chantar ML, Villa E. Faillaci F, et al. Among authors: romagnoli d, d ambrosio f. Hepatology. 2018 Sep;68(3):1010-1024. doi: 10.1002/hep.29911. Hepatology. 2018. PMID: 29604220 Free PMC article.
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19.
Villa E, Critelli R, Lasagni S, Melegari A, Curatolo A, Celsa C, Romagnoli D, Melegari G, Pivetti A, Di Marco L, Casari F, Arioli D, Turrini F, Zuccaro V, Cassaniti I, Riefolo M, de Santis E, Bernabucci V, Bianchini M, Lei B, De Maria N, Carulli L, Schepis F, Gozzi C, Malaguti S, Del Buono M, Brugioni L, Torricelli P, Trenti T, Pinelli G, Bertellini E, Bruno R, Cammà C, d'Errico A. Villa E, et al. Among authors: romagnoli d, d errico a. Blood Adv. 2021 Feb 9;5(3):662-673. doi: 10.1182/bloodadvances.2020003736. Blood Adv. 2021. PMID: 33560382 Free PMC article.
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation.
Lasagni S, Leonardi F, Pivetti A, Di Marco L, Ravaioli F, Serenari M, Gitto S, Critelli RM, Milosa F, Romanzi A, Mancarella S, Dituri F, Riefolo M, Catellani B, Magistri P, Romagnoli D, Celsa C, Enea M, de Maria N, Schepis F, Colecchia A, Cammà C, Cescon M, d'Errico A, di Benedetto F, Giannelli G, Martinez-Chantar ML, Villa E. Lasagni S, et al. Among authors: romagnoli d. Front Oncol. 2022 Sep 8;12:960808. doi: 10.3389/fonc.2022.960808. eCollection 2022. Front Oncol. 2022. PMID: 36158651 Free PMC article.
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma.
Critelli RM, Milosa F, Romanzi A, Lasagni S, Marcelli G, Di Marco L, Pivetti A, Schepis F, Romagnoli D, Mancarella S, Dituri F, Martinez-Chantar ML, Giannelli G, Villa E. Critelli RM, et al. Among authors: romagnoli d. Oncol Lett. 2022 Sep 21;24(5):395. doi: 10.3892/ol.2022.13515. eCollection 2022 Nov. Oncol Lett. 2022. PMID: 36276500 Free PMC article.
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma.
Di Marco L, Pivetti A, Foschi FG, D'Amico R, Schepis F, Caporali C, Casari F, Lasagni S, Critelli RM, Milosa F, Romanzi A, Marcelli G, De Maria N, Romagnoli D, Catellani B, Scianò F, Magistri P, Colecchia A, Sighinolfi P, Di Benedetto F, Martinez-Chantar ML, Villa E. Di Marco L, et al. Among authors: romagnoli d. Liver Transpl. 2023 May 1;29(5):559-563. doi: 10.1097/LVT.0000000000000087. Epub 2023 Feb 8. Liver Transpl. 2023. PMID: 36747351 Free PMC article. No abstract available.
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis.
Ascione A, De Luca M, Melazzini M, Montilla S, Trotta MP, Petta S, Puoti M, Sangiovanni V, Messina V, Bruno S, Izzi A, Villa E, Aghemo A, Zignego AL, Orlandini A, Fontanella L, Gasbarrini A, Marzioni M, Giannini EG, Craxì A; ABACUS Study Group. Ascione A, et al. Infection. 2018 Oct;46(5):607-615. doi: 10.1007/s15010-018-1157-x. Epub 2018 May 28. Infection. 2018. PMID: 29808463
139 results